From: Treatment of Brain AVMs (TOBAS): study protocol for a pragmatic randomized controlled trial
Evaluation | Screening | Pre-entry | Entry | Treatment | Discharge | 6Â months and yearly | 10Â years |
---|---|---|---|---|---|---|---|
Documentation of AVM | X | Â | Â | Â | Â | Â | Â |
Imaginga | X | Â | Â | Â | Â | X | X |
Informed consent | Â | Â | X | Â | Â | Â | Â |
Medical treatment/history | Â | X | Â | Â | Â | Â | Â |
Clinical assessment | Â | X | Â | Â | Â | X | X |
Neurological exam | Â | X | Â | Â | Â | X | X |
Failure to occlude AVM | Â | Â | Â | X | Â | Â | Â |
Number of days in hospital | Â | Â | Â | Â | X | Â | Â |
Discharge disposition | Â | Â | Â | Â | X | Â | Â |
Residual nidus | Â | Â | Â | Â | Â | X | X |
Hemorrhage during FU | Â | Â | Â | Â | Â | X | X |